Efficacy of imidazolquinoline on treatment of condyloma acuminatum of the buccal mucosa.
Autor: | Curi DS; Dentistry Department, Hospital Universitario Professor Edgard Santos, Federal University of Bahia (UFBA), Brazil., Leite-Ribeiro PM; Professor at Dentistry Department, Hospital Universitario Professor Edgard Santos, Federal University of Bahia (UFBA), Brazil., Torregrossa VR; University of Campinas, Brazil., Vieira VC; Dentistry Department, Hospital Universitario Professor Edgard Santos, Federal University of Bahia (UFBA), Brazil., Sarmento VA; Coordinator of Dentistry Department, Hospital Universitario Professor Edgard Santos, Federal University of Bahia (UFBA), Brazil. |
---|---|
Jazyk: | angličtina |
Zdroj: | Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry [Spec Care Dentist] 2017 Jan; Vol. 37 (1), pp. 51-54. Date of Electronic Publication: 2016 Sep 26. |
DOI: | 10.1111/scd.12199 |
Abstrakt: | The condylomata acuminata is a benign epithelial neoplasm induced by papillomavirus, and it is characterized by the proliferation of stratified squamous epithelial tissue that affects the anogenital and oral mucosa. It is considered to be a sexually transmitted disease and has a higher prevalence in individuals infected with human immunodeficiency virus. Various therapies have been used for the removal of lesions, such as cryotherapy, surgical laser and surgical excision, which are painful and scarring. These techniques, however, do not eliminate the virus and relapses are common shortly after treatment. The use of immunomodulators has been proposed to be an alternative treatment, as imidazolquinoline has been shown to be effective in the treatment of lesions in the anogenital region. However, its use in the oral cavity has been the subject of few reports in the literature. Thus, the objective of this study is to describe a case of warts in the labial mucosa of an HIV positive patient using imidazolquinoline 5%. (© 2016 Special Care Dentistry Association and Wiley Periodicals, Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |